Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology biopharmaceutical company, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City. The company's presentation is scheduled for Wednesday, December 4, 2024, from 9:50-10:10 AM EST. A webcast of the presentation will be available and archived for 90 days on Compass' Events page.
Compass Therapeutics (Nasdaq: CMPX), un'azienda biofarmaceutica oncologica in fase clinica, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler a New York City. La presentazione dell'azienda è programmata per mercoledì 4 dicembre 2024, dalle 9:50 alle 10:10 AM EST. Sarà disponibile un webcast della presentazione e archiviato per 90 giorni nella pagina Eventi di Compass.
Compass Therapeutics (Nasdaq: CMPX), una empresa biofarmacéutica oncológica en etapa clínica, ha anunciado su participación en la 36ª Conferencia Anual de Atención Médica de Piper Sandler en Nueva York. La presentación de la empresa está programada para el miércoles 4 de diciembre de 2024, de 9:50 a 10:10 AM EST. Habrá una transmisión web de la presentación y estará archivada durante 90 días en la página de Eventos de Compass.
Compass Therapeutics (Nasdaq: CMPX), 임상 단계의 종양학 바이오제약 회사가 뉴욕에서 열리는 Piper Sandler 제36회 연례 헬스케어 콘퍼런스에 참여한다고 발표했습니다. 회사의 발표는 2024년 12월 4일 수요일 오전 9:50부터 10:10까지 EST로 예정되어 있습니다. 발표의 웹캐스트는 Compass의 이벤트 페이지에서 90일간 제공 및 보관될 예정입니다.
Compass Therapeutics (Nasdaq: CMPX), une entreprise biopharmaceutique en oncologie en phase clinique, a annoncé sa participation à la 36ème Conférence Annuelle de Santé de Piper Sandler à New York. La présentation de l'entreprise est prévue pour le mercredi 4 décembre 2024, de 9h50 à 10h10 EST. Un webinaire de la présentation sera disponible et archivé pendant 90 jours sur la page Événements de Compass.
Compass Therapeutics (Nasdaq: CMPX), ein biopharmazeutisches Unternehmen im Bereich der Onkologie in klinischer Phase, hat seine Teilnahme an der Piper Sandler 36. Jahrestagung zur Gesundheitsversorgung in New York City angekündigt. Die Präsentation des Unternehmens ist für Mittwoch, den 4. Dezember 2024, von 9:50 bis 10:10 Uhr EST angesetzt. Ein Webcast der Präsentation wird verfügbar sein und 90 Tage lang auf der Veranstaltungsseite von Compass archiviert werden.
- None.
- None.
BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Piper Sandler 36th Annual Healthcare Conference taking place in New York City, NY December 3-5, 2024.
Presentation details
Date: Wednesday, December 4, 2024
Time: 9:50-10:10 AM EST
Webcast Link: https://event.webcasts.com/
Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Senior Manager of Communications
media@compasstherapeutics.com
617-500-8099
FAQ
When is Compass Therapeutics (CMPX) presenting at the Piper Sandler Healthcare Conference 2024?
How long will the Compass Therapeutics (CMPX) Piper Sandler conference presentation be available for replay?
Where is the 2024 Piper Sandler Healthcare Conference with Compass Therapeutics (CMPX) being held?
